- Home
- UNCY vs FORA Comparison
UNCY vs FORA Comparison
Compare UNCY & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- FORA
- Stock Information
- Founded
- UNCY 2016
- FORA 2014
- Country
- UNCY United States
- FORA United States
- Employees
- UNCY N/A
- FORA N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- FORA Computer Software: Prepackaged Software
- Sector
- UNCY Health Care
- FORA Technology
- Exchange
- UNCY Nasdaq
- FORA Nasdaq
- Market Cap
- UNCY 74.2M
- FORA 69.4M
- IPO Year
- UNCY 2021
- FORA N/A
- Fundamental
- Price
- UNCY $4.63
- FORA $2.22
- Analyst Decision
- UNCY Strong Buy
- FORA Strong Buy
- Analyst Count
- UNCY 5
- FORA 1
- Target Price
- UNCY $55.20
- FORA $5.00
- AVG Volume (30 Days)
- UNCY 510.5K
- FORA 26.2K
- Earning Date
- UNCY 11-12-2025
- FORA 11-12-2025
- Dividend Yield
- UNCY N/A
- FORA N/A
- EPS Growth
- UNCY N/A
- FORA N/A
- EPS
- UNCY N/A
- FORA N/A
- Revenue
- UNCY N/A
- FORA $25,031,040.00
- Revenue This Year
- UNCY N/A
- FORA $47.82
- Revenue Next Year
- UNCY $4,481.14
- FORA $10.11
- P/E Ratio
- UNCY N/A
- FORA N/A
- Revenue Growth
- UNCY N/A
- FORA 18.59
- 52 Week Low
- UNCY $3.40
- FORA $1.64
- 52 Week High
- UNCY $11.00
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- UNCY 61.71
- FORA 51.97
- Support Level
- UNCY $3.72
- FORA $2.20
- Resistance Level
- UNCY $4.80
- FORA $2.33
- Average True Range (ATR)
- UNCY 0.24
- FORA 0.07
- MACD
- UNCY 0.07
- FORA -0.01
- Stochastic Oscillator
- UNCY 75.00
- FORA 8.11
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.